In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells

Int J Mol Sci. 2023 Oct 26;24(21):15617. doi: 10.3390/ijms242115617.

Abstract

Ageing is an irreversible and inevitable biological process and a significant risk factor for the development of various diseases, also affecting the musculoskeletal system, resulting from the accumulation of cell senescence. The aim of this systematic review was to collect the in vitro studies conducted over the past decade in which cell senescence was induced through various methods, with the purpose of evaluating the molecular and cellular mechanisms underlying senescence and to identify treatments capable of delaying senescence. Through three electronic databases, 22 in vitro studies were identified and included in this systematic review. Disc, cartilage, or muscle cells or tissues and mesenchymal stem cells were employed to set-up in vitro models of senescence. The most common technique used to induce cell senescence was the addition to the culture medium of tumor necrosis factor (TNF)α and/or interleukin (IL)1β, followed by irradiation, compression, hydrogen peroxide (H2O2), microgravity, in vitro expansion up to passage 10, and cells harvested from damaged areas of explants. Few studies evaluated possible treatments to anti-senescence effects. The included studies used in vitro models of senescence in musculoskeletal tissues, providing powerful tools to evaluate age-related changes and pathologies, also contributing to the development of new therapeutic approaches.

Keywords: ageing; cell senescence; in vitro models; musculoskeletal system; systematic review.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Cells, Cultured
  • Cellular Senescence*
  • Hydrogen Peroxide / pharmacology

Substances

  • Hydrogen Peroxide

Grants and funding

The work reported in this publication was granted by the Italian Ministry of Health, under the Aging Network of Italian Research Hospitals (IRCCS)—RCR-2022-23682286-RETE AGING—Next Generation Promising (NGP): a new network approach to frailty, multimorbidity, and age-related disease in the era of precision medicine.